| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥851.3B | ¥999.2B | -14.8% |
| Operating Income | ¥12.2B | ¥13.8B | -11.3% |
| Ordinary Income | ¥10.8B | ¥10.2B | +5.5% |
| Net Income | ¥7.2B | ¥3.7B | +94.1% |
| ROE | 4.2% | 2.4% | - |
FY2026 Q3 cumulative results show revenue of 851.3 billion yen (YoY -14.8%), operating income of 12.2 billion yen (YoY -11.3%), ordinary income of 10.8 billion yen (YoY +5.5%), and net income of 7.2 billion yen (YoY +94.1%). The period was characterized by significant top-line contraction offset by substantial net income improvement, driven primarily by non-operating and below-the-line items rather than core operational gains. Operating margin compressed to 1.4% on a 6.2% gross margin, reflecting a thin-margin EMS business model under revenue pressure. Total assets increased to 769.0 billion yen with equity of 172.2 billion yen, yielding an equity ratio of 22.4% and ROE of 4.2%. The company maintains a high leverage profile with interest-bearing debt of 311.0 billion yen, of which 217.9 billion yen is short-term, creating liquidity pressure evidenced by a current ratio of 97.8%. Basic EPS improved substantially to 24.73 yen from 12.14 yen prior year.
Revenue declined 148.0 billion yen or 14.8% YoY to 851.3 billion yen, representing a substantial contraction in the EMS business which constitutes the company's primary operations. The company disclosed that segments other than EMS are immaterial, indicating this is predominantly a single-segment business exposed to electronics manufacturing services demand. The revenue decrease appears driven by customer demand softness and supply chain adjustments in the electronics industry, with no indication of market share gains or new business wins offsetting the volume decline. Cost of sales decreased proportionally to 799.0 billion yen, maintaining a gross profit of 52.4 billion yen but compressing gross margin to 6.2%, which is characteristic of low-margin contract manufacturing but signals pricing pressure or unfavorable product mix. SG&A expenses of 40.2 billion yen remained relatively fixed despite the revenue decline, resulting in an SG&A ratio increase to 4.7% and contributing to operating margin compression. Operating income fell 1.6 billion yen or 11.3% to 12.2 billion yen, demonstrating that fixed cost absorption deteriorated as revenue declined. The gap between operating income of 12.2 billion yen and ordinary income of 10.8 billion yen represents a negative non-operating contribution of approximately 1.4 billion yen, likely comprising interest expenses on the substantial debt load partially offset by equity method gains or financial income. Ordinary income nonetheless increased 5.5% YoY to 10.8 billion yen, suggesting improved non-operating performance or one-time gains relative to the prior period. Profit before tax reached 11.1 billion yen with tax burden reducing net income to 7.2 billion yen, representing a tax burden factor of 0.645 and resulting in net income growth of 94.1% YoY. This substantial net income improvement despite operating income decline indicates material contribution from extraordinary items, tax adjustments, or minority interest changes that are non-recurring in nature. The performance pattern is revenue down, operating profit down, yet net profit up, indicating structural operational challenges masked by favorable below-the-line adjustments.
[Profitability] ROE of 4.2% reflects low profitability driven by net profit margin of 0.8%, partially offset by total asset turnover of 1.107 and elevated financial leverage of 4.46 times. Operating margin of 1.4% indicates thin operational profitability characteristic of EMS business models, while gross margin of 6.2% suggests limited pricing power or high-volume low-margin contract structures. Net profit margin compression to 0.8% demonstrates the impact of fixed cost deleverage and financial expenses on a declining revenue base. [Cash Quality] Cash and deposits of 110.3 billion yen provide coverage of 0.51 times against short-term borrowings of 217.9 billion yen, indicating constrained liquidity for immediate debt service. Working capital of negative 10.9 billion yen reflects accounts payable of 185.8 billion yen exceeding accounts receivable of 148.0 billion yen, though this is partially offset by inventory holdings. [Investment Efficiency] Asset turnover of 1.107 times demonstrates reasonable asset utilization for a manufacturing business, though ROIC remains low given the thin profit margins. Inventory increased substantially with finished goods rising 10.8 billion yen or 51.4% YoY, suggesting demand weakness or production timing mismatches requiring inventory management attention. Receivables turnover deteriorated with DSO extending to approximately 63 days, representing a 19.5% increase in trade receivables despite declining sales. [Financial Health] Equity ratio of 22.4% indicates high leverage with debt-to-equity of 3.46 times and debt-to-capital of 64.4%, creating financial risk sensitivity to earnings volatility or interest rate changes. Current ratio of 97.8% below the 1.0 threshold flags liquidity concerns, with short-term liabilities of 489.9 billion yen slightly exceeding current assets of 479.0 billion yen. Interest coverage ratio of 3.79 times based on EBIT to interest expense provides modest but not comfortable debt service capacity.
Cash and deposits increased 10.0 billion yen YoY to 110.3 billion yen, representing 14.3% of total assets and providing partial liquidity cushion against the elevated short-term debt position. The cash accumulation despite net income of 7.2 billion yen suggests working capital inflows or financing activities supplemented operating cash generation. Finished goods inventory increased substantially by 10.8 billion yen while accounts receivable rose 24.2 billion yen, implying cash consumption in working capital of approximately 35 billion yen that would offset operating income, though this was countered by accounts payable increasing, which provided supplier credit utilization as a financing source. Short-term borrowings increased 33.0 billion yen to 217.9 billion yen, indicating the company relied on additional short-term debt financing during the period, likely to fund working capital requirements and maintain liquidity. Long-term loans of 93.1 billion yen represent 12.1% of total assets and provide structural funding, though the high proportion of short-term debt at 70.1% of total liabilities creates refinancing risk. The cash coverage ratio of 0.51 times against short-term debt warrants monitoring, as it indicates the company would need to refinance or generate substantial operating cash flow to service maturing obligations. Asset composition shows tangible fixed assets of 204.7 billion yen representing 26.6% of total assets, indicating capital-intensive manufacturing operations that require sustained investment for competitiveness.
Ordinary income of 10.8 billion yen compared to operating income of 12.2 billion yen indicates a net non-operating loss of approximately 1.4 billion yen, representing negative 0.2% of revenue and primarily reflecting interest expenses on the substantial debt load of 311.0 billion yen. The interest burden factor of 0.913 calculated as profit before tax over EBIT shows financial costs reduced pre-tax earnings by approximately 8.7%, consistent with the leverage profile and interest coverage ratio of 3.79 times. Non-operating income composition is not fully disclosed but likely includes financial expenses offsetting any equity method gains or other investment income. The substantial gap between net income growth of 94.1% and operating income decline of 11.3% signals that earnings quality is mixed, with operational performance deteriorating while non-operating and tax factors contributed favorably. The tax burden factor of 0.645 indicates an effective tax rate of approximately 35.5%, which appears within normal corporate tax ranges but the specific drivers of the favorable tax outcome relative to prior year are not disclosed. Operating cash flow data is not available for the quarterly period, preventing direct assessment of cash earnings quality through operating CF to net income comparison. However, the substantial increase in finished goods inventory by 51.4% and accounts receivable by 19.5% despite declining sales suggests potential working capital deterioration that would strain operating cash generation. Accruals analysis is limited without cash flow statement data, but the disconnect between balance sheet working capital movements and income statement performance warrants caution regarding earnings sustainability.
Full-year guidance projects revenue of 1,150.0 billion yen, operating income of 18.0 billion yen, ordinary income of 15.0 billion yen, and EPS of 33.96 yen. Q3 cumulative progress rates stand at 74.0% for revenue, 67.8% for operating income, and 71.7% for ordinary income against full-year targets. Revenue progress of 74.0% aligns closely with the standard Q3 expectation of 75%, suggesting the company is on track to meet full-year sales guidance barring significant Q4 deviation. Operating income progress of 67.8% trails the standard Q3 benchmark by 7.2 percentage points, indicating either conservative full-year guidance or expectation of stronger Q4 operational performance to close the gap. This below-standard progress on operating income suggests the company may be assuming seasonal strength or specific business wins in the final quarter, or alternatively may face risk of missing the operating income target if Q4 performance does not materially exceed Q1-Q3 run rates. Ordinary income progress of 71.7% similarly trails the 75% standard by 3.3 percentage points, though the gap is narrower than operating income, implying relatively stable non-operating assumptions for Q4. Net income progress is not calculable as full-year net income guidance was not provided in the extracted data, though EPS guidance of 33.96 yen implies full-year net income of approximately 9.6 billion yen based on 28.1 million average shares outstanding, which would represent 74.8% achievement through Q3. The forecast notes section was not provided, limiting visibility into management assumptions on demand recovery, cost structure improvements, or one-time factors. Given the substantial inventory build and receivables increase observed through Q3, achievement of Q4 targets likely depends on inventory drawdown, improved asset turnover, and sustained cost discipline.
Annual dividend is projected at 10.00 yen per share for the full fiscal year, consisting of an interim dividend of 5.00 yen and year-end dividend of 5.00 yen, maintaining consistency with the company's stated dividend policy. Based on Q3 cumulative net income of 7.2 billion yen and average shares outstanding of 28.1 million shares, the implied annual dividend payout would be approximately 2.8 billion yen, representing a payout ratio of approximately 39.4% against current earnings run rate. If full-year net income reaches the implied guidance level of approximately 9.6 billion yen based on EPS forecast of 33.96 yen, the payout ratio would approximate 29.4%, which is conservative and sustainable relative to earnings capacity. Comparing to prior year, dividend information for the previous period is not provided in the extracted data, preventing YoY dividend comparison. No share buyback program or results were disclosed in the available data. The total return ratio inclusive of dividends and buybacks cannot be calculated due to absence of buyback information, though the dividend payout ratio alone of approximately 29-39% depending on full-year outcome suggests meaningful retained earnings for debt reduction or reinvestment. Dividend sustainability appears adequate given the payout ratio remains well below 60% threshold and cash position of 110.3 billion yen provides coverage, though this assessment is qualified by the constrained liquidity position with current ratio below 1.0 and high short-term debt burden that may compete for cash resources.
Revenue concentration and demand volatility risk: The company's dependence on EMS business with immaterial other segments creates exposure to electronics industry cyclicality and specific customer demand patterns. The 14.8% revenue decline YoY demonstrates sensitivity to end-market conditions, with limited diversification to offset sector-specific downturns. Customer concentration is not quantified but typical EMS providers face risk from large customer dependency. Liquidity and refinancing risk: Current ratio of 97.8% combined with short-term borrowings of 217.9 billion yen against cash of only 110.3 billion yen creates material liquidity pressure requiring either operating cash flow generation of approximately 107.6 billion yen or successful refinancing to meet obligations. Short-term debt represents 70.1% of total liabilities, concentrating maturity risk in the near term and exposing the company to credit market conditions and lender relationship stability. Profitability compression and margin sustainability risk: Operating margin of 1.4% and gross margin of 6.2% provide minimal buffer against cost inflation, pricing pressure, or operating deleverage. The fixed SG&A cost base of 40.2 billion yen requires revenue of approximately 2,871 billion yen to achieve 1.4% SG&A ratio at current levels, implying significant operating leverage works both ways. Further revenue decline without commensurate cost reduction would quickly erode profitability, while the low margin structure limits investment capacity for growth initiatives or debt reduction.
[Industry Position] (Reference - Proprietary Analysis)
UMC Electronics operates in the manufacturing sector with specific focus on electronics manufacturing services. Comparing to industry benchmarks for 2025-Q3, the company demonstrates below-median profitability and elevated leverage. ROE of 4.2% substantially underperforms the manufacturing industry median of 5.8% (IQR: 3.1%-8.4%, n=105), placing the company in the lower quartile of peer profitability despite elevated financial leverage that typically amplifies returns. Operating margin of 1.4% significantly trails the industry median of 8.9% (IQR: 5.4%-12.7%, n=105), confirming the thin-margin nature of the EMS business model relative to broader manufacturing peers. Net profit margin of 0.8% falls well below the manufacturing median of 6.5% (IQR: 3.3%-9.4%, n=105), indicating structural profitability challenges. The equity ratio of 22.4% contrasts sharply with the industry median of 63.8% (IQR: 49.1%-74.8%, n=105), demonstrating substantially higher leverage than typical manufacturing companies and financial flexibility constraints. Financial leverage of 4.46 times significantly exceeds the industry median of 1.53 times (IQR: 1.31-1.86, n=105), positioning the company in the high-leverage tail of the distribution. Asset turnover of 1.107 times exceeds the manufacturing median of 0.56 times (IQR: 0.41-0.65, n=105), reflecting the working capital-intensive nature of EMS operations versus capital-intensive manufacturing peers. Current ratio of 0.98 times falls dramatically below the industry median of 2.87 times (IQR: 2.13-3.84, n=84), flagging liquidity as a significant outlier risk factor. Receivables turnover of approximately 63 days compares to industry median of 85 days (IQR: 69-117, n=104), indicating relatively efficient collections despite recent deterioration. Return on assets of 0.9% implied by net income and assets substantially underperforms the industry median of 3.4% (IQR: 1.8%-5.2%, n=105), confirming weak asset productivity. The company's revenue decline of 14.8% YoY significantly lags the industry median growth of 2.8% (IQR: -1.5% to 8.8%, n=105), indicating company-specific or subsector challenges beyond general manufacturing trends. Source: Proprietary analysis of manufacturing sector, 2025-Q3 data.
The earnings data reveals a company navigating substantial operational headwinds with revenue contraction of 14.8% pressuring an already thin-margin business model, while financial structure constraints and liquidity metrics warrant attention. Operating margin compression to 1.4% and net margin of 0.8% position profitability well below manufacturing sector medians, indicating either structural positioning in commodity EMS services or execution challenges requiring business model reassessment. The substantial net income improvement of 94.1% despite operational deterioration highlights the importance of distinguishing recurring operational performance from non-recurring below-the-line contributions when evaluating earnings sustainability. Asset turnover of 1.107 times exceeding industry medians demonstrates relatively efficient asset utilization, though this is offset by thin margins resulting in ROA and ROE substantially below sector benchmarks. The inventory increase of 51.4% in finished goods concurrent with revenue decline signals potential demand forecasting challenges or customer order volatility requiring working capital management focus. Financial structure with equity ratio of 22.4% versus industry median of 63.8% and current ratio of 0.98 versus industry median of 2.87 represents material outlier positioning on both leverage and liquidity dimensions, creating refinancing risk and financial flexibility constraints that limit strategic options. Dividend policy maintaining 10 yen per share with payout ratio of approximately 29-39% appears sustainable from an earnings coverage perspective, though free cash flow assessment is limited by data availability and the constrained liquidity position suggests cash allocation priorities may favor debt reduction. The guidance progress with operating income at 67.8% of full-year target through Q3 versus standard expectation of 75% implies either conservative forecasting or dependency on significant Q4 performance improvement, warranting monitoring of actual Q4 outcomes against implied quarterly targets.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.